{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05222906",
            "orgStudyIdInfo": {
                "id": "EFC17215"
            },
            "secondaryIdInfos": [
                {
                    "id": "U1111-1265-6930",
                    "type": "REGISTRY",
                    "domain": "ICTRP"
                },
                {
                    "id": "2024-514381-39",
                    "type": "REGISTRY",
                    "domain": "CTIS"
                },
                {
                    "id": "2021-005402-10",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Sanofi",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3",
            "officialTitle": "A Phase 3, Multicenter, Multinational, Randomized, Double-blind, Double-dummy, Active-comparator Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3 (GD3) Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ERT)",
            "acronym": "LEAP2MONO",
            "therapeuticArea": [
                "Other"
            ],
            "study": "study-to-evaluate-the-efficacy-and-safety-of-venglustat-in-adult-and-pediatric-patients-with-gaucher-disease-type"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-04-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-10-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-01-20",
            "studyFirstSubmitQcDate": "2022-02-01",
            "studyFirstPostDateStruct": {
                "date": "2022-02-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-09",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Sanofi",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a parallel arm, Phase 3, double-blind, double-dummy, active-comparator, 2 arm study to evaluate the efficacy and safety of daily oral venglustat versus intravenous Cerezyme infusions every two weeks for improvement or stabilization of the neurological manifestations and maintenance of systemic disease stability in participants aged \u226512 and \\<18 years and adult patients with Gaucher disease Type 3 (GD3) who have been treated with Enzyme Replacement Therapy (ERT) for at least 3 years.",
            "detailedDescription": "Screening period: 45 days\n\nDouble blind, double-dummy, primary analysis treatment period: 52 weeks\n\nOpen label extended treatment period: minimum of 52 weeks due to a common study end of treatment date\n\nFollow up phone call: 30-37 days after end of treatment"
        },
        "conditionsModule": {
            "conditions": [
                "Gaucher's Disease Type III"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Double Dummy",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "maskingDescription": "During the open-label extended treatment period all participants will receive open label venglustat.",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Venglustat",
                    "type": "EXPERIMENTAL",
                    "description": "Venglustat",
                    "interventionNames": [
                        "Drug: Venglustat"
                    ]
                },
                {
                    "label": "Cerezyme",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Cerezyme",
                    "interventionNames": [
                        "Drug: imiglucerase"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Venglustat",
                    "description": "tablet; oral",
                    "armGroupLabels": [
                        "Venglustat"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "imiglucerase",
                    "description": "sterile lyophilized product; intravenous",
                    "armGroupLabels": [
                        "Cerezyme"
                    ],
                    "otherNames": [
                        "Cerezyme\u00ae"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in Scale for Assessment and Rating of Ataxia (SARA) modified total score",
                    "timeFrame": "From baseline to Week 52"
                },
                {
                    "measure": "Change in Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) total scale index score",
                    "timeFrame": "From baseline to Week 52"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Percent change in spleen volume",
                    "timeFrame": "From baseline to Week 52"
                },
                {
                    "measure": "Percent change in liver volume",
                    "timeFrame": "From baseline to Week 52"
                },
                {
                    "measure": "Change in hemoglobin level",
                    "timeFrame": "From baseline to Week 52"
                },
                {
                    "measure": "Percent change in platelet count",
                    "timeFrame": "From baseline to Week 52"
                },
                {
                    "measure": "Percent change in CSF GL-1 and lyso GL-1 levels",
                    "timeFrame": "From baseline to Week 52"
                },
                {
                    "measure": "Percent change in plasma GL-1 and lyso GL-1 levels",
                    "timeFrame": "From baseline to Week 52"
                },
                {
                    "measure": "Number of patients with treatment emergent adverse events (TEAEs)/ serious adverse events (SAEs)/ adverse events of special interest (AESIs)",
                    "timeFrame": "From baseline to max of 3.5 years"
                },
                {
                    "measure": "Change in score of Beck Depression Inventory II (BDI-II) during the treatment-emergent period (for participants 13 years of age and above at baseline)",
                    "timeFrame": "From baseline to Week 52"
                },
                {
                    "measure": "Change in Patient Health Questionnaire 9 (PHQ-9) during the treatment-emergent period (for participants 12 years of age at baseline)",
                    "timeFrame": "From baseline to Week 52"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* The participant has received ERT (Cerezyme or other ERT; as deemed appropriate by local regulations) for at least 3 years prior to enrollment, on a stable dose for at least 6 months, is deemed clinically stable for at least 1 year by the Investigator and is within the therapeutic goals as all of the following:\n\n  * Hemoglobin level of \u226511.0 g/dL for females and \u226512.0 g/dL for males\n  * Platelet count \u2265100 000/mm3\n  * Spleen volume \\<10 multiples of normal (MN)\n  * Liver volume \\<1.5 MN\n  * No bone crisis and free of symptomatic bone disease such as bone pain attributable to osteonecrosis and/or pathological fractures within 3 months prior to screening\n* Adult participant is \u226518 years of age\n* Pediatric participant is \u226512 years \\<18 years of age\n* The participant has a clinical diagnosis of GD3 and a documented deficiency of acid beta-glucosidase activity confirming this diagnosis.\n* The participant has a modified SARA score of 1 or above.\n* The presence of gaze palsy, predominantly horizontal, with slow or absent saccades.\n* If the participant has a history of seizures, they are well controlled under appropriate medication not identified as a strong or moderate inducer or inhibitor of CYP3A.\n* Participants \u2265 30 kg of weight\n* Contraception for sexually active male or female participants; not pregnant or breastfeeding; no sperm donating for male participant\n* Signed written informed assent/consent\n\nExclusion Criteria:\n\n* The participant is blood transfusion-dependent.\n* Prior esophageal varices or liver infarction or current liver enzymes (alanine aminotransferase \\[ALT\\]/ aspartate aminotransferase \\[AST\\]) or total bilirubin \\>2 times the upper limit of normal, unless the participant has a diagnosis of Gilbert Syndrome.\n* The participant has any clinically significant disease, other than GD, including cardiovascular (congenital cardiac defect, coronary artery disease, valve disease or left sided heart failure; clinically significant arrhythmias or conduction defect), hepatic, gastrointestinal, pulmonary, neurologic, endocrine, metabolic (eg, hypokalemia, hypomagnesemia) or psychiatric disease, other medical conditions, or serious intercurrent illnesses that may preclude participation in the opinion of the Investigator.\n* The participant has renal insufficiency, as defined by an estimated glomerular filtration rate \\<30 mL/min/1.73m2 at the screening visit.\n* The participant has a history of cancer, except for basal cell carcinoma.\n* The participant has progressive myoclonic epilepsy.\n* The participant is pregnant (has a positive serum beta-human chronic gonadotropin \\[\u03b2-hCG\\]) or lactating.\n* The participant requires use of invasive ventilatory support.\n* The participant requires use of noninvasive ventilator support while awake for longer than 12 hours daily.\n* The participant is scheduled for in-patient hospitalization including elective surgery, during the study.\n* The participant has had a major organ transplant (eg, bone marrow or liver).\n* A history of drug and/or alcohol abuse within the past year prior to the screening visit.\n* Chaperone therapy within 6 months, substrate reduction therapy other than venglustat within 6 months or venglustat substrate reduction therapy prior to enrollment.\n* Exposure to any investigational drug (including venglustat) within the last 30 days or 5 half-lives from screening, whichever is longer.\n* The participant has received strong or moderate inducers or inhibitors of CYP3A within 14 days or 5 half-lives from screening, whichever is longer, prior to screening. This also includes the consumption of grapefruit, grapefruit juice, or grapefruit containing products within 72 hours of starting venglustat. The participant is unwilling to abstain from consumption of grapefruit, grapefruit juice, or grapefruit containing products for the duration of the treatment period.\n* The participant, in the opinion of the investigator, is unable to adhere to the requirements of the study or unable to undergo study assessments (eg, contraindication for MRI).\n* Type of participant and disease characteristic: the participant has had a total splenectomy prior to enrollment. The patient had a partial splenectomy within 3 years prior to randomization.\n* Participant not suitable for participation, whatever the reason, as judged by the Investigator, including medical or clinical conditions, or participants potentially at risk of noncompliance to study procedures\n* Sensitivity to any of the study interventions, or components thereof, or drug or other allergy that, in the opinion of the Investigator, contraindicates participation in the study\n\nThe above information is not intended to contain all considerations relevant to a potential participation in a clinical trial.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "12 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Trial Transparency email recommended (Toll free for US & Canada)",
                    "role": "CONTACT",
                    "phone": "800-633-1610",
                    "phoneExt": "option 6",
                    "email": "contact-us@sanofi.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Sciences & Operations",
                    "affiliation": "Sanofi",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Yale University School of Medicine - Investigational Site Number: 8400003",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06511",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ruhua N Yang",
                            "role": "CONTACT",
                            "phone": "203-785-3412",
                            "email": "ruhua.yang@yale.edu"
                        },
                        {
                            "name": "Pramod Mistry, Dr.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "University of Iowa - Investigational Site Number: 8400002",
                    "status": "RECRUITING",
                    "city": "Iowa City",
                    "state": "Iowa",
                    "zip": "52242",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Teresa R. Kopel",
                            "role": "CONTACT",
                            "phone": "319-467-8147",
                            "email": "teresa-kopel@uiowa.edu"
                        },
                        {
                            "name": "John Bernat",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.66113,
                        "lon": -91.53017
                    }
                },
                {
                    "facility": "Texas Oncology - Medical City Dallas Site Number : 8400008",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75230",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Gina Ross",
                            "role": "CONTACT",
                            "phone": "972-566-2321",
                            "email": "gina.ross@usoncology.com"
                        },
                        {
                            "name": "Maurizio Ghisoli, Dr.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Lysosomal & Rare Disorders Research & Treatment Center, Inc - Investigational Site Number: 8400001",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lauren Knoll",
                            "role": "CONTACT",
                            "phone": "571-732-4655",
                            "email": "lnoll@idrtc.org"
                        },
                        {
                            "name": "Ozlem Goker-Alpan, Dr.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Hospital de Ninos - Investigational Site Number: 320001",
                    "status": "RECRUITING",
                    "city": "Buenos Aires",
                    "zip": "1426",
                    "country": "Argentina",
                    "contacts": [
                        {
                            "name": "Barbara Soberon",
                            "role": "CONTACT",
                            "phone": "+54 911 5008 6908",
                            "email": "bsoberon@live.com"
                        },
                        {
                            "name": "Guillermo Drelichman, Dr.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -34.61315,
                        "lon": -58.37723
                    }
                },
                {
                    "facility": "Children's Hospital Research Institute of Manitoba - Investigational Site Number: 1240001",
                    "status": "RECRUITING",
                    "city": "Winnipeg",
                    "state": "Manitoba",
                    "zip": "R3E 3P4",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Amy Yakimoski",
                            "role": "CONTACT",
                            "phone": "204-789-3779",
                            "email": "AYakimoski@chrim.ca"
                        },
                        {
                            "name": "Cheryl Greenberg, Dr.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 49.8844,
                        "lon": -97.14704
                    }
                },
                {
                    "facility": "National Taiwan University Hospital-Investigational Site Number: 1580001",
                    "status": "RECRUITING",
                    "city": "Taipei",
                    "state": "Taiwan",
                    "zip": "10041",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Tsung-Lin Huang",
                            "role": "CONTACT",
                            "phone": "+886-2-23123456",
                            "phoneExt": "#71941",
                            "email": "tsunglin71941@gmail.com"
                        },
                        {
                            "name": "Ni-Chung Lee, Dr.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ]
                },
                {
                    "facility": "Peking Union Medical College Hospital - Investigational Site Number: 1560001",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "zip": "100005",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Rui Gao",
                            "role": "CONTACT",
                            "phone": "010-69155727",
                            "email": "rui.gao@globalaes.com"
                        },
                        {
                            "name": "Zhengqing Qiu, Professor",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "The First Affiliated Hospital - Investigational Site Number: 1560002",
                    "status": "RECRUITING",
                    "city": "Guangzhou",
                    "zip": "510080",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Yaxuan Chen",
                            "role": "CONTACT",
                            "phone": "+86 02087608185",
                            "email": "yaxuan.chen@globalaes.com"
                        },
                        {
                            "name": "Xuequn Luo, Dr.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 23.11667,
                        "lon": 113.25
                    }
                },
                {
                    "facility": "Xinhua Hospital - Investigational Site Number: 1560004",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "zip": "200092",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Yawen Shi",
                            "role": "CONTACT",
                            "email": "Yawen.Shi@globalaes.com"
                        },
                        {
                            "name": "Huiwen Zhang, Dr.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "47-87, boulevard de l'h\u00f4pital - Investigational Site Number: 2500003",
                    "status": "RECRUITING",
                    "city": "Paris",
                    "zip": "75013",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Carine Lefort",
                            "role": "CONTACT",
                            "email": "carine.lefort@aphp.fr"
                        },
                        {
                            "name": "Nadjar Yann, Dr.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Hopital Necker - Investigational Site Number: 2500001",
                    "status": "RECRUITING",
                    "city": "Paris",
                    "zip": "75015",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Kahina Abdallah",
                            "role": "CONTACT",
                            "phone": "+33 142754845",
                            "email": "kahina.abdallah-ext@aphp.fr"
                        },
                        {
                            "name": "Anais Brassier, Doctor",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "SphinCS GmbH - Investigational Site Number: 2760001",
                    "status": "RECRUITING",
                    "city": "Hochheim am Main",
                    "zip": "65239",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Petra Kleinhans",
                            "role": "CONTACT",
                            "phone": "+49 06146 904820",
                            "email": "petra.kleinhans@sphincs.de"
                        },
                        {
                            "name": "Mengel Eugen, Dr.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.01436,
                        "lon": 8.35218
                    }
                },
                {
                    "facility": "Debreceni Egyetem, Klinikai K\u00f6zpont, Reumatol\u00f3giai Klinika - Investigational Site Number: 3480001",
                    "status": "RECRUITING",
                    "city": "Debrecen",
                    "zip": "H-4032",
                    "country": "Hungary",
                    "contacts": [
                        {
                            "name": "\u00c9va R\u00c1K\u00d3CZI",
                            "role": "CONTACT",
                            "phone": "+36 303166216",
                            "email": "bbereczki@med.unideb.hu"
                        },
                        {
                            "name": "\u00c9va R\u00c1K\u00d3CZI, Dr.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.53333,
                        "lon": 21.63333
                    }
                },
                {
                    "facility": "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Investigational Site Number : 3800003",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Milano",
                    "state": "Lombardia",
                    "zip": "20122",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Irene Motta",
                            "role": "CONTACT",
                            "phone": "+39 0255033548",
                            "email": "irene.motta@policlinico.mi.it"
                        },
                        {
                            "name": "Irene Motta",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Azienda Ospedaliera Universitaria (AOU) \"Federico II\" - Investigational Site Number: 3800002",
                    "status": "RECRUITING",
                    "city": "Napoli",
                    "zip": "80131",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Antonio Barbato",
                            "role": "CONTACT",
                            "phone": "+39 347 478 0102",
                            "email": "abarbato@unina.it"
                        },
                        {
                            "name": "Domenico Rendina, Dr",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.85216,
                        "lon": 14.26811
                    }
                },
                {
                    "facility": "Investigational Site Number : 3920002",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Odawara-shi",
                    "state": "Kanagawa",
                    "zip": "250-8558",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.25556,
                        "lon": 139.15972
                    }
                },
                {
                    "facility": "Tohoku University School of Medicine - Investigational Site Number: 3920001",
                    "status": "RECRUITING",
                    "city": "Sendai",
                    "zip": "980-8574",
                    "country": "Japan",
                    "contacts": [
                        {
                            "name": "Yoichi Wada, Doctor",
                            "role": "CONTACT",
                            "phone": "+81-22-717-7287",
                            "email": "wada@med.tohoku.ac.jp"
                        },
                        {
                            "name": "Yoichi Wada, Dr.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.26667,
                        "lon": 140.86667
                    }
                },
                {
                    "facility": "Investigational Site Number : 7920002",
                    "status": "RECRUITING",
                    "city": "Ankara",
                    "zip": "06500",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 39.91987,
                        "lon": 32.85427
                    }
                },
                {
                    "facility": "Investigational Site Number : 7920001",
                    "status": "RECRUITING",
                    "city": "Balcali Adana",
                    "zip": "01330",
                    "country": "Turkey"
                },
                {
                    "facility": "Investigational Site Number : 7920004",
                    "status": "RECRUITING",
                    "city": "Istanbul",
                    "zip": "34093",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 41.01384,
                        "lon": 28.94966
                    }
                },
                {
                    "facility": "Investigational Site Number : 8260001",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "NW3-2PF",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Investigational Site Number : 8260002",
                    "status": "NOT_YET_RECRUITING",
                    "city": "London",
                    "zip": "WC1N 3JH",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "link to the study specific website Sanofistudies.com for more information about this clinical study and a direct connection to the investigational sites in the US region.",
                    "url": "http://www.sanofistudies.com/MJYO/"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Qualified researchers may request access to patient level data and related study documents including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan, and dataset specifications. Patient level data will be anonymized and study documents will be redacted to protect the privacy of trial participants. Further details on Sanofi's data sharing criteria, eligible studies, and process for requesting access can be found at: https://vivli.org"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005776",
                    "term": "Gaucher Disease"
                },
                {
                    "id": "D000004194",
                    "term": "Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000013106",
                    "term": "Sphingolipidoses"
                },
                {
                    "id": "D000020140",
                    "term": "Lysosomal Storage Diseases, Nervous System"
                },
                {
                    "id": "D000020739",
                    "term": "Brain Diseases, Metabolic, Inborn"
                },
                {
                    "id": "D000001928",
                    "term": "Brain Diseases, Metabolic"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000008661",
                    "term": "Metabolism, Inborn Errors"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000008064",
                    "term": "Lipidoses"
                },
                {
                    "id": "D000008052",
                    "term": "Lipid Metabolism, Inborn Errors"
                },
                {
                    "id": "D000016464",
                    "term": "Lysosomal Storage Diseases"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000052439",
                    "term": "Lipid Metabolism Disorders"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M8891",
                    "name": "Gaucher Disease",
                    "asFound": "Gaucher Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15904",
                    "name": "Sphingolipidoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M18871",
                    "name": "Lysosomal Storage Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5205",
                    "name": "Brain Diseases, Metabolic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22498",
                    "name": "Brain Diseases, Metabolic, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11641",
                    "name": "Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M11064",
                    "name": "Lipidoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M11054",
                    "name": "Lipid Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27029",
                    "name": "Lipid Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T2449",
                    "name": "Gaucher Disease",
                    "asFound": "Gaucher Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2454",
                    "name": "Gaucher Disease Type 3",
                    "asFound": "Gaucher Disease Type 3",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5335",
                    "name": "Sphingolipidosis",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000608118",
                    "term": "Venglustat"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M349697",
                    "name": "Venglustat",
                    "asFound": "FLT3-ITD",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}